Lincoln Pharmaceuticals Ltd announced the resignation of Pradeep Kumar Yadav, Senior General Manager of Quality Assurance, effective October 17, 2026. The departure, attributed to personal reasons, marks a change in the company's senior management personnel as defined under regulatory norms.

Regulatory disclosure details

The company filed an intimation with both the National Stock Exchange of India Limited and BSE Limited under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing confirms that Mr. Yadav served as a designated Senior Management Personnel before his cessation.

The resignation was accepted to be relieved on October 17, 2026, after close of business hours. The company disclosed that a copy of the resignation letter setting out the reasons for the change was enclosed with the filing.

Key personnel changes

The disclosure further noted that brief profile details and director relationship disclosures were not applicable as this was a resignation rather than an appointment.

Lincoln Pharmaceuticals declared a final dividend of ₹1.80 per equity share for the financial year ended March 31, 2026. This payout was approved by shareholders during the company's 32nd Annual General Meeting held on September 30, 2026.

The meeting, conducted via video conferencing, saw members adopt the audited standalone and consolidated financial statements for FY26. The board also re-appointed Mr. Hashmukh I. Patel and Mr. Munjal Mahendrabhai Patel as directors following their retirement by rotation. Additionally, the remuneration of cost auditors M/s. Kiran J. Mehta & Co. was ratified at ₹2,50,000 per annum plus applicable taxes.

Voting Results and Approvals

All five resolutions proposed at the AGM were passed with the requisite majority. The voting pattern showed strong shareholder support for financial adoption and director appointments, with dissenting votes remaining negligible or under 5% across all items.

Operational Updates Shared at AGM

During the meeting, Managing Director Mahendra G. Patel provided an overview of recent operational developments. Key highlights included:

• The launch of four new divisions in the domestic market.
• Growth in export volumes alongside expanded manufacturing capacity.
• Operational status of the Mehsana plant and the new API facility at Khatraj.
• Sustainability initiatives where wind and solar projects meet 100% of the company's energy requirements.

The MD noted that international markets contributed approximately 62% to total sales, while domestic markets accounted for 38%.

What the Numbers Show

The voting data reveals a clear distinction in shareholder sentiment between routine administrative approvals and governance-related appointments. While the declaration of the dividend and the ratification of auditor fees received near-unanimous support (100.00% assent), the re-appointment of directors Hashmukh I. Patel and Munjal M. Patel saw a dissent rate of approximately 4.5% each. This divergence suggests that while shareholders are aligned with financial distributions and compliance matters, there is a minor segment of the investor base that may have reservations regarding specific board compositions, although this did not impede the passage of the resolutions.